Authored By: Sarah
11 Jul 2024

 Preclinical Isolated Organ Perfusion System Market to grow by USD 137.63 million between 2024-2028

According to a research report “ Preclinical Isolated Organ Perfusion System Market” by End-user (Industrial laboratories and CROs, Academic and government research institutes) Type (Isolated heart perfusion systems, Isolated abdominal organ perfusion systems, Isolated lung perfusion systems, Cell isolation and others) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 137.63 million at a CAGR of over 4.86% during the forecast period. Preclinical isolated organ perfusion systems play a pivotal role in the research and development of novel therapeutics for escalating chronic conditions, such as cancer, cardiovascular diseases, and respiratory diseases. The Centers for Disease Control and Prevention (CDC) reports that approximately 60% of adult Americans grapple with at least one chronic disease, with cardiovascular diseases accounting for one life lost every 36 seconds in the US. This translates to 18.2 million adults aged 20 and above afflicted with coronary artery diseases in the US alone. These statistics underscore the significance of the preclinical isolated organ perfusion system market in advancing medical breakthroughs and addressing unmet healthcare needs..

Browse market data tables, figures, and in-depth TOC on “Preclinical Isolated Organ Perfusion System Market” by End-user (Industrial laboratories and CROs, Academic and government research institutes) Type (Isolated heart perfusion systems, Isolated abdominal organ perfusion systems, Isolated lung perfusion systems, Cell isolation and others) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028.

 View detailed Table of Content- Click here

By End-user, the Industrial laboratories and CROs segment is projected to dominate the market size in 2024.

The preclinical isolated organ perfusion system market is poised for expansion due to the escalating burden of cardiovascular diseases worldwide. With sedentary lifestyles and an aging population, the incidence and prevalence of cardiovascular conditions are on the rise, leading to a significant demand for advanced medical solutions. Europe alone reports approximately 5.7 million cardiovascular disease-related deaths annually, driving research and innovation in the development of new therapeutics. Key market players are capitalizing on this trend by offering state-of-the-art isolated organ perfusion systems, further fueling market growth.

By Type, Isolated heart perfusion systems  segment is expected to hold the largest market size for the year 2024.

In the realm of drug discovery and development, industrial laboratories, including pharmaceutical and biotechnology firms, and Contract Research Organizations (CROs), play pivotal roles. These entities, equipped with essential infrastructure, execute preclinical and clinical investigations on potential drug candidates. The industrial laboratories and CROs sector is poised for expansion due to escalating pharmaceutical investments in research and surging outsourcing trends to CROs. Pharmaceutical and biotech enterprises focus on creating drugs for diverse therapeutic applications, expanding globally at an impressive rate. Within this context, the Preclinical Isolated Organ Perfusion System market experiences significant growth, as these advanced systems facilitate efficient and accurate drug testing in a controlled laboratory environment.

North America is forecasted to hold the largest market size by region in 2024.

In North America, the preclinical isolated organ perfusion system market is poised for steady expansion. Key drivers include the presence of major industry players like Harvard Bioscience Inc., Radnoti LLC, and emka TECHNOLOGIES. Advanced technologies and products, such as isolated organ perfusion systems, are increasingly adopted in preclinical research, fueled by substantial funding and research advancements in life sciences. Established pharmaceutical companies and research institutes further bolster market growth in the region.

The Preclinical Isolated Organ Perfusion System Market t growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • ADInstruments Pty Ltd.
  • ALA Scientific Instruments Inc.
  • emka TECHNOLOGIES
  • Harvard Bioscience Inc.
  • MDE GmbH
  • Radnoti LLC
  • World Precision Instruments
  • XVIVO Perfusion AB
.

For insights on company offerings- Request a sample report!

Research Analysis Overview

In the realm of preclinical research and biologics manufacturing, the market for Isolated Organ Perfusion Systems (IOPS) has gained significant traction. IOPS, which include Bioreactor Perfusion Systems and both Hypothermic and Normothermic Machine Perfusion Systems, play a crucial role in the preservation and function assessment of various organs, such as the heart, lung, kidney, brain, and others. These systems employ advanced technologies like Cannulas, Monitoring Systems, Oxygenators, Perfusion Pumps, and Heart-Lung Machines to maintain the physiological conditions necessary for organ survival. IOPS are extensively utilized in cell perfusion systems and cardiopulmonary perfusion systems for cardiovascular research, organ donation, and the development of drugs for conditions like coronary artery disease, disability, stroke, and cancer. The market for IOPS is driven by the increasing demand for organ transplantation and the growing interest in cell-based research. These systems offer a cost-effective and ethical alternative to animal models and whole organ transplantation, making them indispensable in the healthcare products industry.

Market Research Overview

The Preclinical Isolated Organ Perfusion System Market encompasses innovative solutions for preserving and maintaining organ function outside the body for extended periods. New product releases in this domain include Gravity Perfusion Systems, Microfluidic Perfusion Systems, and Bioreactor Perfusion Systems, among others. These systems facilitate Inorganic Growth and Scalability in the healthcare industry, particularly in the field of Biologics Manufacturing and Cell-based Research. Value chain scrutiny reveals key components such as Cannulas, Monitoring Systems, Oxygenators, Perfusion Pumps, Heart-Lung Machines, and Cell Perfusion Systems. Hindrances to market growth include regulatory challenges and high investment requirements. Industry Coverage extends to various applications, including Organ Donation, Healthcare Products, Drugs, Private Healthcare, and the treatment of conditions like Coronary Artery Disease, Disability, Stroke, Cardiovascular Diseases, Organ Transplantation, Chemotherapy, Brain Injuries, Kidney Diseases, and Lung Diseases. Isolated Organ Perfusion plays a crucial role in the development of Normothermic and Hypothermic Machine Perfusion systems, enhancing the overall efficiency and effectiveness of these systems.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio